News for Amgen Inc. (AMGN)

U.S. stocks are down sharply in negative territory Monday afternoon, with those from technology sector suffering more pronounced losses, amid rising concerns about the outlook for economic growth and corporate earnings.

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

[url="]Bristol Myers Squibb[/url] (NYSE:BMY) today announced positive data from the pivotal Phase 3 POETYK PsA-2 trial (IM011-055) evaluating the efficacy and

PR NewswireVANCOUVER, BC, March 8, 2025 USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, March 8, 2025 /PRNewswire/

Amgen Inc (AMGN) and Kyowa Kirin Co., Ltd. have released new results from their ROCKET Phase 3 clinical trial program, evaluating rocatinlimab, a T-cell rebalan

Budweiser keeps pushing higher. AI segments moving down. Bitcoin in short and long-term. Economy not looking as sweet.

In this article, we will take a look into Amgen Inc's (AMGN) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of usi

**media[559681]**

**media[559663]**

Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stocks are under siege as Donald Trump's tariffs take effect. Here's where six investing gurus recommend investing your money right now.

Amgen Inc. AMGN has kicked off two crucial phase three trials for MariTide, its investigational weight loss injection. This move marks a significant step in the...

We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look at where Amgen Inc.

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive Vice...

On March 5th, BBC reported that the US stock market had fallen after the tariffs sparked trade war fear.

Amgen Inc (AMGN), a leading biotechnology company, announced on March 4, 2025, that its Board of Directors has declared a $2.38 per share dividend for the secon

PR NewswireTHOUSAND OAKS, Calif., March 4, 2025 THOUSAND OAKS, Calif., March 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

PR NewswireJERSEY CITY, N.J., March 3, 2025 STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of referenc